PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsTetracycline
Tetracycline
Achromycin, Bismuth / Metronidazole / Tetracycline, Pylera, Sumycin, Tetracycline, Tetracyn, Tetrex (tetracycline) is a small molecule pharmaceutical. Tetracycline was first approved as Achromycin on 1982-01-01. It is used to treat acne vulgaris, bacterial eye infections, bacterial infections, bartonella infections, and borrelia infections amongst others in the USA.
Download report
Favorite
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
eye diseasesD005128
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
Achromycin, Sumycin, Tetracycline (discontinued: Achromycin, Actisite, Bristacycline, Cyclopar, Panmycin, Retet, Robitet, Sumycin, Tetracycline, Tetracyn, Tetramed, Tetrex, Topicycline)
Combinations
Bismuth subcitrate potassium, metronidazole tetracycline, Bismuth subsalicylate, metronidazole tetracycline (discontinued: Achromycin, Helidac, Tetracyn)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydrocortisone
+
Tetracycline hydrochloride
Tradename
Company
Number
Date
Products
ACHROMYCINLederle LaboratoriesN-050272 DISCN1982-01-01
1 products
Hide discontinued
Procaine hydrochloride
+
Tetracycline hydrochloride
Tradename
Company
Number
Date
Products
ACHROMYCINLederle LaboratoriesN-050276 DISCN1982-01-01
2 products
Hide discontinued
Tetracycline hydrochloride
Tradename
Company
Number
Date
Products
ACHROMYCIN VAvet PharmaceuticalsN-050278 RX1982-01-01
2 products, RLD
Show 6 discontinued
Bismuth subsalicylate
+
Metronidazole
+
Tetracycline hydrochloride
Tradename
Company
Number
Date
Products
HELIDACCasper PharmaN-050719 DISCN1996-08-15
1 products, RLD
Hide discontinued
Tetracycline phosphate complex
Tradename
Company
Number
Date
Products
TETREXBristol Myers SquibbN-050212 DISCN1982-01-01
2 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
acnecyclineOTC monograph final2011-02-15
apt t3x tetracycline hydrochloride first aid antibioticC2002632023-12-01
bismuth subcitrate potassium, metronidazole and tetracycline hydrochlorideANDA2024-12-27
bismuth subcitrate potassium, metronidazole, and tetracycline hydrochlorideNew Drug Application2024-07-25
bismuth subcitrate potassium, metronidazole, tetracycline hydrochlorideANDA2024-10-22
bismuth subsalicylate/metronidazole/tetracycline hydrochlorideANDA2019-11-24
dermaclineOTC monograph final2016-11-08
diabeclineOTC monograph final2013-07-12
dyabetexOTC monograph final2010-09-05
honestly battleborn first aid for real manC2002632025-04-07
Show 15 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
acne vulgarisEFO_0003894D000152L70
bacterial infections—D001424A49
gonorrheaDOID_7551D006069A54
cholera—D002771A00
campylobacter infectionsEFO_0007190D002169—
chlamydia infectionsEFO_0007205D002690A74.9
helicobacter infectionsEFO_1000961D016481—
bronchitis—D001991J40
streptococcal infectionsEFO_1001476D013290—
bartonella infectionsEFO_0007166D001474A44
Show 45 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A01: Stomatological preparations
— A01A: Stomatological preparations
— A01AB: Antiinfectives and antiseptics for local oral treatment
— A01AB13: Tetracycline
— A02: Drugs for acid related disorders
— A02B: Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
— A02BD: Combinations for eradication of helicobacter pylori
— A02BD02: Lansoprazole, tetracycline and metronidazole
— A02BD08: Bismuth subcitrate, tetracycline and metronidazole
D: Dermatologicals
— D06: Antibiotics and chemotherapeutics for dermatological use
— D06A: Antibiotics for topical use
— D06AA: Tetracycline and derivatives, topical antibiotics
— D06AA04: Tetracycline
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01A: Tetracycline antibiotics
— J01AA: Tetracyclines
— J01AA07: Tetracycline
— J01R: Combinations of antibacterials
— J01RA: Combinations of antibacterials
— J01RA08: Tetracycline and oleandomycin
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AA: Antibiotics, ophthalmologic
— S01AA09: Tetracycline
— S02: Otologicals
— S02A: Antiinfective drugs, otologic
— S02AA: Antiinfectives
— S02AA08: Tetracycline
— S03: Ophthalmological and otological preparations
— S03A: Antiinfectives, ophthalmologic and otologic
— S03AA: Antiinfectives
— S03AA02: Tetracycline
HCPCS
Code
Description
J0120
Injection, tetracycline, up to 250 mg
J2460
Injection, oxytetracycline hcl, up to 50 mg
Clinical
Clinical Trials
786 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acne vulgarisD000152EFO_0003894L70—1—1—2
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTetracycline
INNtetracycline
Description
Tetracycline is a broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria. It has a role as an antimicrobial agent, an antibacterial drug, an antiprotozoal drug, a protein synthesis inhibitor and an Escherichia coli metabolite. It is a tertiary alpha-hydroxy ketone and a member of tetracyclines. It is a conjugate acid of a tetracycline(1-) and a tetracycline zwitterion.
Classification
Small molecule
Drug classantibiotics (tetracycline derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12
Identifiers
PDB—
CAS-ID60-54-8
RxCUI—
ChEMBL IDCHEMBL1440
ChEBI ID27902
PubChem CID54675776
DrugBankDB00759
UNII IDF8VB5M810T (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Tetracycline
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 55,825 documents
View more details
Safety
Black-box Warning
Black-box warning for: Bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride, Bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride, Bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride, Bismuth subsalicylate/metronidazole/tetracycline hydrochloride, Pylera
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
4,635 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use